| Literature DB >> 20376578 |
Corina Lorz1, Ramón García-Escudero, Carmen Segrelles, Marina I Garín, José M Ariza, Mirentxu Santos, Sergio Ruiz, María F Lara, Ana B Martínez-Cruz, Clotilde Costa, Agueda Buitrago-Pérez, Cristina Saiz-Ladera, Marta Dueñas, Jesús M Paramio.
Abstract
Continuous cell renewal in mouse epidermis is at the expense of a pool of pluripotent cells that lie in a well defined niche in the hair follicle known as the bulge. To identify mechanisms controlling hair follicle stem cell homeostasis, we developed a strategy to isolate adult bulge stem cells in mice and to define their transcriptional profile. We observed that a large number of transcripts are underexpressed in hair follicle stem cells when compared to non-stem cells. Importantly, the majority of these downregulated genes are involved in cell cycle. Using bioinformatics tools, we identified the E2F transcription factor family as a potential element involved in the regulation of these transcripts. To determine their functional role, we used engineered mice lacking Rb gene in epidermis, which showed increased expression of most E2F family members and increased E2F transcriptional activity. Experiments designed to analyze epidermal stem cell functionality (i.e.: hair regrowth and wound healing) imply a role of the Rb-E2F axis in the control of stem cell quiescence in epidermis.Entities:
Mesh:
Year: 2010 PMID: 20376578 PMCID: PMC2887512 DOI: 10.1007/s12015-010-9139-0
Source DB: PubMed Journal: Stem Cell Rev Rep ISSN: 2629-3277 Impact factor: 5.739
Currently published datasets for the molecular profile of the hair follicle stem cells. aDataset accession number to Gene Expression Omnibus, http:www.ncbi.nlm.nih.gov/geo; N-LCM: navigated laser capture microdissection; LRCs: label-retaining cells
| Authors, year Accession | Platform Chip | Probe sets | Species | Selection marker / method | GSEA using MACS CD34+ HFSC signature | FDR q-value |
|---|---|---|---|---|---|---|
| C. Lorz et al. | Affymetrix | ∼ 45,000 | Mouse | CD34 / MACS | – | – |
| GSE19448a | Mouse430_2 | |||||
| V. Greco et al. 2009 | Affymetrix | ∼ 22,000 | Mouse | K14GFP-CD34 / | 452 | 0.0002 |
| GSE15185a | MOE430A_2 | FACS | ||||
| C.S. Trempus et al., 2007 | Agilent | ∼ 22,000 | Mouse | CD34 / FACS | 783 | <0.0001 |
| GSE7690a | ||||||
| M. Ohyama et al., 2006 | Affymetrix | ∼ 22,000 | Human | LRCs / N-LCM | 334 | <0.0001 |
| GSE3419a | HG_U133A | |||||
| R.J. Morris et al., 2004 | Affymetrix | ∼ 12,000 | Mouse | K15GFP / FACS | 495 | <0.0001 |
| GSE1096a | MG_U74Av | |||||
| T. Tumbar et al., 2004 | Affymetrix | ∼ 12,000 | Mouse | LRCs / FACS | 331 | <0.0001 |
|
| MG_U74Av2 |
Fig. 1CD34 is a marker of follicular stem cells. Immunofluorescent labeling for CD34 a and K15 (a´) HFSC markers in a telogen hair follicle. In the merged image (a´´), the region double labeled with CD34 and K15 (dashed line) corresponds to the bulge, where true hair follicle stem cells reside. The region positive only for K15 (dotted line) corresponds to the hair germ (HG). Dermal papilla (DP) thin continuous line; * autofluorescence from hair shaft. b & c) Flow cytometry dot plots of backskin keratinocytes preparations from telogen transgenic mice that express GFP under the control of the K15 promoter. b Forward and side scatter analysis (FSC and SSC) reveal that CD34 and K15 positive cell populations are partially overlapping. c Analysis of CD34 surface expression and K15-GFP epifluorescence reveals keratinocyte populations positive for both markers (upper right quadrant), only positive for K15-GFP (lower right quadrant), and a CD34+ population that shows no detectable activation of the K15 promoter (upper left quadrant). d CD34+ keratinocytes show different level of Itgα6 expression
Fig. 2Magnetic cell sorting (MACS) as a method for HFSC isolation. a Whole backskin keratinocytes preparations are fluorescent and magnetic labelled for the bulge surface marker CD34. In telogen mice the CD34+ population represents about 8% of the total. b Keratinocytes are passed through a column in the presence of a magnetic field and the CD34 negative fraction is collected; the column is then removed from the magnetic field and the CD34 positive fraction is eluted. Due to fluorescent label pre-and post-sort fractions can be assessed for CD34 enrichment by FACS and immunofluorescence. CD34+ population is represented by the peak at the right (not detectable in the CD34−fraction) in the FACS histogram plots and by the events that fall in the lower left quadrant of the FACS dot plots. Adapted from C. Lorz et al., Epidermal Cells: Methods and Protocols [30]
Fig. 3Gene expression analysis of HFSC. a Heat map showing differential regulation of known hair follicle stem cell markers in CD34+ HFSC isolated using MACS. b Gene Ontology analysis [68, 69] reveals overrepresented Biological Processes within the differentially regulated genes in HFSC (overexpressed genes in red, uderexpressed genes in green). Note that cell cycle related genes are among the most frequently downregulated genes in HFSC, while the expression of cell communication/adhesion genes is enriched in HFSC
The KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis tool in DAVID [58, 59] was used to search for the most relevant pathways present in the 2,297-probe HFSC signature. The table shows genes over-or underexpressed within each pathway in this cell population. NR: non-relevant. Default cutoff for functional annotation charts is 1.0E-1 (0.1)
| Pathway | Genes (UP/DOWN) | p-value | Gene symbol | p-value UP/DOWN | |
|---|---|---|---|---|---|
| Cell Cycle | 37 (1 / 36) | 1.4E-7 | UP | Crebbp | NR |
| DOWN | Bub1, Bub1b, Cdc2a, Cdc6, Cdc7, Cdc20, Chek1, Ccna2, Ccnb1, Ccnb2, Ccnd1, Ccnd2, Ccne2, Cdk2, Cdk4, Cdk6, Cdkn1a, Dbf4, Fzr1, Hdac2, Mcm2, Mcm3, Mcm4, Mcm5, Mcm6, Mcm7, Pcna, Rbl1, Rbl2 , Trp53, Sfn, Ywhab, Ywhah, Ywhaq, Ywhaz, Wee1 | 8.3E-10 | |||
| Wnt signaling | 35 (13 / 22) | 9.3E-4 | UP | Crebbp, Ctbp2, Daam1, Fzd1, Fzd2, Fzd7, Nfatc5, Nfatc1, Nkd1, Sfrp1, Tcf3, Tcf4, Wif1 | 1.0E-3 |
| DOWN | Axin2, Chp, Csnk2a1, Ccnd1, Ccnd2, Map3k7, Nfatc3, Prickle1, Prkcb1, Prkacb, Rock1, Siah1a, Siah1b, Senp2, Tcf7, Tbl1x, Trp53, Wnt10a, Wnt3, Wnt3a, Wnt5a, Wnt7b | 9.9E-2 | |||
| p53 signaling | 19 (0 / 19) | 1.8E-3 | UP | – | – |
| DOWN | Casp8, Cdc2a, Chek1, Ccnb1, Ccnb2, Ccnd1, Ccnd2, Ccne2, Cdk2, Cdk4, Cdk6,Cdkn1a, Igfbp3, Pmaip1, Rrm2, Siah1a, Siah1b, Sfn, Trp53 | 9.2E-5 | |||
| Hedgehog signaling | 14 (6 / 8) | 2.2E-2 | UP | Bmp6, Gli1, Gli2, Gli3, Gas1, Hhip | 1.8E-2 |
| DOWN | Bmp4, Csnk1d, Prkacb, Wnt10a, Wnt3, Wnt3a, Wnt5a, Wnt7b | NR | |||
| Adherens junctions | 17 (5 / 12) | 4.3E-2 | UP | Actn1, Crebbp, Fgfr1, Tcf3, Tcf4 | NR |
| DOWN | Acp1, Actb, Cdh1, Csnk2a1, Mapk1, Map3k7, Pvrl2, Pvrl3, Ptpn6, Tcf7, Tgfbr2, Wasl | NR | |||
| Cell communication | 24 (13/11) | 6.2E-2 | UP | Fn1, Krt6a, Krt75, Col1a1, Col1a2, Col3a1, Col4a4, Col5a1, Col5a2, Col6a1, Col6a2, Krt24, Tnc | 1.9E-4 |
| DOWN | Krt79, Actb, Dsg2, Gjb4, Itga6, Itgb4, Krt14, Lmna, Col4a6, Krt77, Thbs2 | NR | |||
| Apoptosis | 18 (3/15) | 6.8E-2 | UP | Bcl2, Capn2, Akt3 | NR |
| DOWN | Capn1, Casp8, Chp, Dffa, Il1rap, Il1r1, Irak3, Nfkbia, Nfkb2, Pik3cb, Prkar1a, Prkacb, Ripk1, Tradd, Trp53 | 7.1E-2 |
Transcription factor motif gene sets enriched in the promoter region of the genes upregulated in the 2,297-probe HFSC signature as described in MSigDB (GSEA molecular signatures database). aHFSC ON: genes overexpressed in HFSC that contain within their promoter region a binding motif for that transcription factor; Total, refers to the total number of targets in the expression array. NES: Normalized enrichment score; FDR: False discovery rate
| Gene or family | Motif gene sets | aHFSC ON/ Total | NES | FDR q-val |
|---|---|---|---|---|
| Homeobox | YTAATTAA_LHX3_01 | 40 / 138 | 2.06 | 0.010 |
| S8_01 | 53 / 179 | 1.96 | 0.016 | |
| POU6F1_01 | 41 / 178 | 1.86 | 0.019 | |
| POU3F2_02 | 46 / 187 | 1.87 | 0.020 | |
| HNF6_Q6 | 49 / 182 | 1.91 | 0.021 | |
| LHX3_01 | 51 / 171 | 1.84 | 0.021 | |
| CDX2_Q5 | 42 / 184 | 1.87 | 0.022 | |
| NKX62_Q2 | 52 / 171 | 1.79 | 0.027 | |
| CHX10_01 | 38 / 173 | 1.67 | 0.058 | |
| OCT1_02 | 42 /157 | 1.68 | 0.061 | |
| Paired box | PAX4_04 | 30 / 157 | 2.01 | 0.013 |
| PAX8_B | 10 / 73 | 1.66 | 0.057 | |
| Forkhead box | HFH4_01 | 38 / 152 | 2.11 | 0.016 |
| FOXJ2_01 | 25 / 138 | 1.66 | 0.056 | |
| FOXD3_01 | 40 / 159 | 1.84 | 0.021 | |
| RE1-silencing transcription factor | NRSF_01 | 45 / 71 | 1.90 | 0.019 |
| GATA binding | GATA1_04 | 57 / 177 | 1.82 | 0.022 |
| GATA_Q6 | 40 / 142 | 1.64 | 0.060 | |
| CCAAT/enhancer binding protein gamma | CEBPGAMMA_Q6 | 21 / 184 | 1.75 | 0.034 |
| T-cell acute lymphocytic leukemia 1 Transcription factor 3 | TAL1BETAE47_01 | 44 / 177 | 1.67 | 0.056 |
Transcription factor motif gene sets enriched in the promoter region of the genes downregulated in the 2,297-probe HFSC signature as described in MSigDB (GSEA molecular signatures database). aHFSC OFF: genes underexpressed in HFSC that contain within their promoter region a binding motif for that transcription factor; Total, refers to the total number of targets in the expression array. NES: Normalized enrichment score, for repressed genes in a given dataset (HFSC) NES values are negative; FDR: False discovery rate
| Gene or family | Motif gene sets | aHFSC OFF / Total | NES | FDR q-val |
|---|---|---|---|---|
| E2F transcription factor | E2F_Q4 | 75 / 165 | −2.35 | <0.0001 |
| E2F_Q3_01 | 80 / 166 | −2.17 | <0.0001 | |
| E2F1_Q6 | 68 / 163 | −2.14 | <0.0001 | |
| E2F1DP1RB_01 | 68 / 160 | −2.23 | <0.0001 | |
| RB, Retinoblastoma | E2F4DP2_01 | 67 / 162 | −1.87 | 0.003 |
| DP1, E2F dimerization partner 1 | E2F1DP2_01 | 67 / 162 | −1.86 | 0.003 |
| DP2, E2F dimerization partner 2 | E2F4DP1_01 | 66 / 167 | −1.82 | 0.004 |
| E2F1DP1_01 | 67 / 162 | −1.85 | 0.003 | |
| SGCGSSAAA_E2F1DP2_01 | 52 / 117 | −2.00 | 0.001 | |
| GTGACGY_E4F1_Q6 | 193 / 447 | −2.00 | 0.001 | |
| Nuclear respiratotry factor | NRF2_01 | 93 / 165 | −2.26 | <0.0001 |
| GABP_B | 98 / 159 | −2.17 | 0.001 | |
| NRF1_Q6 | 76 / 159 | −1.98 | 0.001 | |
| ETS transcription factor | TEL2_Q6 | 74 / 156 | −2.11 | <0.0001 |
| ETS_Q4 | 83 / 178 | −2.07 | <0.0001 | |
| ELK1_01 | 87 / 176 | −1.97 | 0.001 | |
| ELK1_02 | 93 / 170 | −1.78 | 0.006 | |
| CETS1P54_01 | 72 / 176 | −1.76 | 0.007 | |
| Yin yang transcription factor 1 | GCCATNTTG_YY1_Q6 | 148 / 296 | −1.87 | 0.003 |
Fig. 4Analysis of gene expression regulation in HFSC. a Schematic representation of the 5’ ends proximal to the transcriptional initiation sites of Lhx2, Lgr5 and Nfatc1 showing the potential binding sites for the transcription factors mentioned, as obtained using MatInspector software [35]. b Heat map of the expression pattern of genes with E2F-binding sites within their promoters (overexpressed genes in red, underexpressed genes in blue). Note that the majority of the genes are underexpressed in CD34+ HFSC. Highlighted in red are E2F transcription factors
Fig. 5pRb regulates stem cell quiescence. a qRT-PCR analysis of the expression of the different E2F members in Rb-deficient keratinocytes. Values were normalized with respect to each E2F member expression in control keratinocytes. b Luciferase assay showing increased E2F activity in Rb-deficient keratinocytes. The data were normalized to Renilla activity and correspond to three independent experiments. They are shown as mean fold induction ± standard error. c Summary of four independent FACS experiments showing the percentage of CD34+/Itgα6+ cells from control and Rb-deficient mice. d Quantification of BrdU-positive label retaining cells (LRC) after a 75-day chase in control and Rb-deficient mice (Rbf/f; K14Cre). Data come from the study of five different mice, 2–4 independent sections from each animal were analyzed counting at least 100 follicles per section (mean ± standard error). (e and e´) Representative skin sections showing BrdU-positive cells in follicles from LRC experiments. Insets show higher magnification of BrdU-positive labeled cells. Bars = 150 μm; Rbf/f, control mice; Rbf/f; K14Cre, Rb-deficient mice
Fig. 6pRb ablation in epidermis accelerates hair regrowth. a Representative skin sections from control and Rb-deficient mice at different time points after induction of hair regrowth by depilation. Note premature anagen induction in Rb-deficent mice. Incipient anagen hairs are denoted by arrows. Bar = 250 μm. b Representative macroscopic appearance of dorsal skin sections from control and Rb-deficient mice at different time points after depilation. Note the presence of massive hair regrowth in mutant mice 6 days after depilation. Bar = 1 cm. c Histogram summarizing anagen induction data obtained from histological analyses as those shown in (a). Data in c come from the quantification of 5 sections (2 cm length) of 10 mice of each genotype and are shown as mean ± SD. Statistical significances analyzed by two tailed tTest were (*) p ≤ 0.001, (**) p ≤ 0.005. Rbf/f, control mice; Rbf/f; K14Cre, Rb-deficient mice
Fig. 7pRb ablation in epidermis accelerates skin wound healing. a Representative skin sections from control and Rb-deficient mice at different time points after wounding. Note the accelerated wound closure in mutant mice. Bar = 1 cm. b Plot summarizing the quantitative analysis of wound closure obtained from 4 different wounds induced in 4 different mice of each genotype. Data are shown as mean ± SE. c Haematoxylin-eosin stained sections of control and Rb-deficient mice showing the wound margins (denoted by arrows). Higher magnifications of the squared areas show the re-epithelialization front. d Keratin 5 immunostaining also demonstrates advanced re-epithelialization in pRb-deficient mice. Arrows denote initial wound margins. e BrdU-stained sections showing increased cell proliferation at the wound margins in Rb-deficient mice. Dashed lines denote the dermal-epidermal borders. F) Hematoxylin-eosin and sirius red staining of representative sections 10 days after wounding in control and Rb-deficient mice. The maturation of collagen fibers, denoted by intense red staining is slightly accelerated in Rb-deficient mice. Wound margins are still detected in control mice (arrows). Bars in c, d, e, f = 150 µm; Rbf/f, control mice; Rbf/f; K14Cre, Rb-deficient mice